| Glucose pentaacetate Basic information |
| Product Name: | Glucose pentaacetate |
| Synonyms: | Pentaacetate Pentaacetyl-alpha-D-glucose;ALPHA-D-GLUCOPYRANOSE-PENTAACETATE;ALPHA-GLUCOSE PENTAACETATE;A-D-GLUCOSE PENTAACETATE;D-A-GLUCOSE PENTAACETATE;1,2,3,4,6-PENTA-O-ACETYL-A-D-GLUCOPYRANOSE;1,2,3,4,6-PENTA-O-ACETYL-A-GLUCOPYRANOSE;1,2,3,4,6-PENTA-O-ACETYL-ALPHA-D-GLUCOPYRANOSE |
| CAS: | 604-68-2 |
| MF: | C16H22O11 |
| MW: | 390.34 |
| EINECS: | 210-073-2 |
| Product Categories: | chiral;Biochemistry;Glucose;O-Substituted Sugars;Sugars;Dextrins,Sugar & Carbohydrates;Carbohydrates & Derivatives |
| Mol File: | 604-68-2.mol |
 |
|
| Glucose pentaacetate Chemical Properties |
| Melting point | 111-113 °C |
| alpha | 97 º (c=1, CHCl3) |
| Boiling point | 435.58°C (rough estimate) |
| density | 1.3984 (rough estimate) |
| FEMA | 2524 | GLUCOSE PENTAACETATE |
| refractive index | 105.5 ° (C=1.5, MeOH) |
| solubility | chloroform: 0.1 g/mL, clear, colorless |
| form | Powder |
| color | White to off-white |
| optical activity | [α]20/D ≥+98°, c = 1 in ethanol |
| Water Solubility | < 5 G/L (25 ºC) |
| BRN | 98852 |
| CAS DataBase Reference | 604-68-2(CAS DataBase Reference) |
| NIST Chemistry Reference | «alpha»-D-Glucopyranose, pentaacetate(604-68-2) |
| EPA Substance Registry System | .alpha.-D-Glucopyranose, pentaacetate (604-68-2) |
| Safety Information |
| Hazard Codes | Xn,Xi |
| Risk Statements | 21-36/38-46-62-63 |
| Safety Statements | 24/25-53-36/37-26-25 |
| WGK Germany | 3 |
| TSCA | Yes |
| HS Code | 29400000 |
| MSDS Information |
| Provider | Language |
|---|---|
| 1,2,3,4,6-Penta-O-acetyl-alpha-D-glucopyranose | English |
| SigmaAldrich | English |
| ACROS | English |
| ALFA | English |
| Glucose pentaacetate Usage And Synthesis |
| Chemical Properties | white to light yellow crystal powde |
| Uses | D-Glucose pentaacetate was reported to stimulate insulin release in rat pancreatic islets. Only α-D-glucose pentaacetate caused an immediate increase in insulin output. The β-anomer of D-glucose pentaacetate first transiently inhibited insulin release, this initial effect being followed by a secondary rise in secretory rate. |
| Purification Methods | Crystallise it from MeOH, EtOH or three recrystallisations from 95% EtOH. [Wolfrom & Thompson Methods in Carbohydrate Chemistry II 212 1963, Academic Press, Beilstein 17/7 V 318.] |
| Glucose pentaacetate Preparation Products And Raw materials |